Skip to main content
$17.88 $1.32 (8.0%)

03:59 PM EST on 12/08/21

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)

CAPS Rating: No stars

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe.

Current Price $17.88 Mkt Cap $177.1M
Open $16.61 P/E Ratio 135.42
Prev. Close $17.88 Div. (Yield) $0.00 (0.0%)
Daily Range $16.30 - $18.05 Volume 31,870
52-Wk Range $8.19 - $24.26 Avg. Daily Vol. 50,076

Caps

How do you think NASDAQ:CLGN will perform against the market?

Add Stock to CAPS Watchlist

All Players

1 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CLGN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CLGN VS S&P 500 (SPY)

NASDAQ:CLGN Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CLGN.

Recs

0
Member Avatar FVelociraptor (32.08) Submitted: 10/26/2021 12:02:46 PM : Outperform Start Price: $22.42 NASDAQ:CLGN Score: -23.07

https://velociraptor.cc

Leaderboard

Find the members with the highest scoring picks in CLGN.

Score Leader

HDTVBG

HDTVBG (68.42) Score: -6.25

The Score Leader is the player with the highest score across all their picks in CLGN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. FVelociraptor 32.08 10/26/2021 Outperform 5Y $22.42 -20.25% +2.82% -23.07 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CLGN.